Meera Narasimhan to Antipsychotic Agents
This is a "connection" page, showing publications Meera Narasimhan has written about Antipsychotic Agents.
Connection Strength
0.981
-
Simplifying adherence in schizophrenia. Psychiatr Serv. 2010 Apr; 61(4):405-8.
Score: 0.296
-
Metabolic syndrome in patients with schizophrenia: CATIE results. Curr Psychiatry Rep. 2006 Jun; 8(3):213-4.
Score: 0.227
-
Improving adherence to antipsychotic pharmacotherapy. Curr Clin Pharmacol. 2006 Jan; 1(1):47-56.
Score: 0.220
-
Long-acting injectable vs oral risperidone for schizophrenia and co-occurring alcohol use disorder: a randomized trial. J Clin Psychiatry. 2015 Oct; 76(10):1359-65.
Score: 0.108
-
A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorder. J Clin Psychopharmacol. 2015 Jun; 35(3):319-23.
Score: 0.106
-
Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale. Eur Neuropsychopharmacol. 2015 Feb; 25(2):176-84.
Score: 0.025